Despite the frequency with which people are convicted of multiple DUI offenses, California continues to require that all individuals with a DUI attend a 30- or 60-hour education program. However, these programs aren't that effective.
Due to budget concerns the federal government just shut down a critical data source that provides insights into abuse, dependence on, and spending on heroin and other hard drugs like crack and methamphetamine.
Currently, evidence for the safety, harmfulness, utility, and addictiveness of e-cigarettes is lacking. The questions that research needs to answer, however, are clear as day—particularly since business is booming.
CVS Caremark will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores beginning Oct. 1. Though it stands to lose $2 billion dollars in annual revenue, CVS CEO Larry J. Merlo said that selling tobacco products is at odds with the company's mission of improving health outcomes.
Anti-tobacco policies that have clear scientific support will strengthen the FDA's regulatory position. While the evidence base is solid in this area, it needs to be much stronger and broader if the TCA is going to have any lasting success against the industry.
Driving Mexican marijuana out of the U.S. would probably reduce the traffickers' export revenue by a few billion dollars a year, writes Beau Kilmer. But would reducing that revenue lead to a corresponding decrease in trafficker violence?
Policymakers in Washington and Colorado are confronting some new and tricky issues that have never been addressed. For them, and for anyone else thinking about changing their pot laws, there are seven key decision areas that will shape the costs and benefits of marijuana legalization.